Tabula Rasa HealthCare (NASDAQ:TRHC) adds US$24m to market cap in the past 7 days, though investors from five years ago are still down 89%

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shareholders should be happy to see the share price up 18% in the last week. But that doesn't change the fact that the returns over the last half decade have been stomach churning. Five years have seen the share price descend precipitously, down a full 89%. While the recent increase might be a green shoot, we're certainly hesitant to rejoice. The important question is if the business itself justifies a higher share price in the long term. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

While the last five years has been tough for Tabula Rasa HealthCare shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

Check out our latest analysis for Tabula Rasa HealthCare

Given that Tabula Rasa HealthCare didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

In the last half decade, Tabula Rasa HealthCare saw its revenue increase by 8.8% per year. That's a pretty good rate for a long time period. So the stock price fall of 14% per year seems pretty steep. The market can be a harsh master when your company is losing money and revenue growth disappoints.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
NasdaqGM:TRHC Earnings and Revenue Growth June 9th 2023

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

We're pleased to report that Tabula Rasa HealthCare shareholders have received a total shareholder return of 66% over one year. That certainly beats the loss of about 14% per year over the last half decade. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a (positive) inflection point within the business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 3 warning signs for Tabula Rasa HealthCare you should be aware of, and 1 of them is potentially serious.